Theleme Partners LLP: TRANSUNION (TRU): Quarterly 13F Position History
As of Q1 2026, Theleme Partners LLP reported 2,316,882 shares of TRANSUNION (TRU), worth $160.3M and representing 10.7% of its 13F equity book. Quarter-over-quarter share count change: + 86,000 (+3.9%) . The position first appeared in Q1 2024 and has been disclosed across 9 13F-HR filings in Pactolio's tracked window.
- 2,316,882Shares Held (Latest Filing)
- $160.3MReported Market Value (Latest Filing)
- 10.7%Portfolio Weight (% of 13F Equity Book)
- +86,000Quarter-over-Quarter Share Change
- -$31.0MQuarter-over-Quarter Value Change
- 2,316,882Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 9 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 2,316,882 | +86,000 | +3.9% | $160.3M | 10.7% | $69.2 |
| Q4 2025 | 2,230,882 | 0 | — | $191.3M | 12.5% | $85.8 |
| Q3 2025 | 2,230,882 | +122,525 | +5.8% | $186.9M | 11.9% | $83.8 |
| Q2 2025 | 2,108,357 | +293,000 | +16.1% | $185.5M | 11.3% | $88.0 |
| Q1 2025 | 1,815,357 | +335,000 | +22.6% | $150.7M | 11.8% | $83.0 |
| Q4 2024 | 1,480,357 | 725,000 | -32.9% | $137.2M | 9.2% | $92.7 |
| Q3 2024 | 2,205,357 | 75,802 | -3.3% | $230.9M | 13.6% | $104.7 |
| Q2 2024 | 2,281,159 | +896,000 | +64.7% | $169.2M | 8.4% | $74.2 |
| Q1 2024 | 1,385,159 | — | — | $110.5M | 6.1% | $79.8 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Theleme Partners LLP first disclose a TRU position in 13F-HR filings?
Theleme Partners LLP first reported TRANSUNION (TRU) on its 13F-HR filing for the period ending 2024-03-31 (Q1 2024). The position has appeared on 9 reported quarters within Pactolio's tracked window.
What was Theleme Partners LLP's most recent quarter-over-quarter share-count change in TRU?
Between Q4 2025 and Q1 2026, Theleme Partners LLP added 86,000 shares of TRU (+3.9%), bringing the total reported position to 2,316,882 shares at a market value of $160.3M.
Does the implied price-per-share represent Theleme Partners LLP's cost basis in TRU?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.